NASDAQ:BDSX
Biodesix Inc Stock News
$1.55
+0 (+0%)
At Close: May 08, 2024
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
05:00pm, Tuesday, 09'th Apr 2024
LOUISVILLE, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data was prese
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
06:00am, Friday, 16'th Feb 2024
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release finan
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
09:04am, Friday, 26'th Jan 2024
Despite the recent economic deceleration, positive factors like a tight labor market and strong consumer spending support a resilient U.S. economy. Goldman Sachs predicts increased state and local gov
Biodesix, Inc. (BDSX) Q3 2023 Earnings Call Transcript
01:24pm, Saturday, 11'th Nov 2023
Biodesix, Inc. (NASDAQ:BDSX ) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper C
Biodesix to Participate in Two Upcoming Investor Conferences in November
06:00am, Thursday, 09'th Nov 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Execut
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
06:00am, Tuesday, 24'th Oct 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus on lung disease, announced today that it will release finan
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
06:00am, Tuesday, 03'rd Oct 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that new data will be pres
Why You Should Bet on 4 Top-Ranked Stocks With Rising P/E
08:17am, Friday, 08'th Sep 2023
Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include OI Glass (OI), KE Hodlings (BEKE), Biodesix (BDSX) and Phunware (PHUN).
Biodesix to Participate in Two Upcoming Investor Conferences in September
06:00am, Tuesday, 05'th Sep 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton,
Biodesix, Inc. (BDSX) Reports Q2 Loss, Tops Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.40 per share a year ago.
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
06:00am, Monday, 24'th Jul 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will r
Biodesix, Inc. (BDSX) Q1 2023 Earnings Call Transcript
11:53am, Sunday, 14'th May 2023
Biodesix, Inc. (NASDAQ:BDSX ) Q1 2023 Earnings Conference Call May 11, 2023 6:00 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates
07:02pm, Thursday, 11'th May 2023
Biodesix, Inc. (BDSX) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.50 per share a year ago.
Biodesix to Report First Quarter 2023 Financial Results on May 11, 2023
06:00am, Thursday, 27'th Apr 2023
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus on lung disease, announced today that it will r
Biodesix, Inc. (BDSX) Q4 2022 Earnings Call Transcript
10:09am, Monday, 06'th Mar 2023
Biodesix, Inc. (NASDAQ:BDSX ) Q4 2022 Earnings Conference Call March 6, 2023 8:00 AM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowi